A Third Vaccine Dose in Organ-Transplant Recipients It is known that people receiving
immune suppressive therapy, such as recipients of solid-organ transplants, have a suboptimal …

The introduction of technologies such as mass spectrometry and protein and DNA arrays,
combined with our understanding of the human genome, has enabled simultaneous …

Delayed dosing intervals are a strategy to immunize a greater proportion of the population.
In an observational study, we compared humoral and cellular responses in health care …

Solid organ transplant recipients are at high risk of severe disease from COVID-19. We
assessed the immunogenicity of mRNA-1273 vaccine using a combination of antibody testing, …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent
of coronavirus disease 2019 (COVID-19). Molecular-based testing is used to diagnose …

A "bottom-up" proteomics approach and a two-dimensional (strong cation exchange followed
by reversed-phase) LC-MS/MS strategy on a linear ion trap (LTQ) were utilized to identify …

Despite widespread interest, few serum biomarkers have been introduced to the clinic over
the past 20 years. Each approach to ovarian cancer biomarker discovery has its own …

Detection of lung cancer at an early stage is necessary for successful therapy and improved
survival rates. We performed a bottom-up proteomics analysis using a two-dimensional LC-…

Current ovarian cancer biomarkers are inadequate because of their relatively low diagnostic
sensitivity and specificity. There is a need to discover and validate novel ovarian cancer …

OBJECTIVES: The aim of this study was to develop high-throughput, quantitative and highly
selective mass spectrometric, targeted immunoassays for clinically important proteins in …